These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34849317)

  • 41. Differences in utility elicitation methods in cardiovascular disease: a systematic review.
    Blieden Betts M; Gandra SR; Cheng LI; Szatkowski A; Toth PP
    J Med Econ; 2018 Jan; 21(1):74-84. PubMed ID: 28899233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ordering errors, objections and invariance in utility survey responses: a framework for understanding who, why and what to do.
    Wittenberg E; Prosser LA
    Appl Health Econ Health Policy; 2011 Jul; 9(4):225-41. PubMed ID: 21682351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic searching and selection of health state utility values from the literature.
    Papaioannou D; Brazier J; Paisley S
    Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic review of health state utility values for economic evaluation of colorectal cancer.
    Jeong K; Cairns J
    Health Econ Rev; 2016 Dec; 6(1):36. PubMed ID: 27541298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.
    Hendrix N; Kim DD; Patel KS; Devine B
    Med Decis Making; 2021 Apr; 41(3):366-372. PubMed ID: 33451278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review of utility values for chemotherapy-related adverse events.
    Shabaruddin FH; Chen LC; Elliott RA; Payne K
    Pharmacoeconomics; 2013 Apr; 31(4):277-88. PubMed ID: 23529208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A review of health utilities across conditions common in paediatric and adult populations.
    Tarride JE; Burke N; Bischof M; Hopkins RB; Goeree L; Campbell K; Xie F; O'Reilly D; Goeree R
    Health Qual Life Outcomes; 2010 Jan; 8():12. PubMed ID: 20105304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
    Ahmad H; Taylor BV; van der Mei I; Colman S; O'Leary BA; Breslin M; Palmer AJ
    Mult Scler; 2017 Jul; 23(8):1157-1166. PubMed ID: 27698247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities.
    Peeters Y; Stiggelbout AM
    Value Health; 2010; 13(2):306-9. PubMed ID: 19744288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Internet-based utility assessment of breast hypertrophy.
    Chang WT; Collins ED; Kerrigan CL
    Plast Reconstr Surg; 2001 Aug; 108(2):370-7. PubMed ID: 11496177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sagittal craniosynostosis: a utility outcomes study.
    Kuta V; McNeely PD; Walling S; Bezuhly M
    J Neurosurg Pediatr; 2017 Aug; 20(2):113-118. PubMed ID: 28524791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Imai T; Tanaka S; Kawakami K; Miyazaki T; Hagino H; Shiraki M;
    Osteoporos Int; 2017 Jun; 28(6):1893-1901. PubMed ID: 28265719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eliciting public preferences for healthcare: a systematic review of techniques.
    Ryan M; Scott DA; Reeves C; Bate A; van Teijlingen ER; Russell EM; Napper M; Robb CM
    Health Technol Assess; 2001; 5(5):1-186. PubMed ID: 11262422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health state utilities for metastatic breast cancer in Taiwan.
    Chou TC; Chiang SC; Ko Y
    Breast; 2020 Jun; 51():57-64. PubMed ID: 32213442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An updated systematic review of Health State Utility Values for osteoporosis related conditions.
    Peasgood T; Herrmann K; Kanis JA; Brazier JE
    Osteoporos Int; 2009 Jun; 20(6):853-68. PubMed ID: 19271098
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.